[go: up one dir, main page]

SV1998000003A - Proceso para producir eters de oxima (z)-azabiciclo en un unico recipiente - Google Patents

Proceso para producir eters de oxima (z)-azabiciclo en un unico recipiente

Info

Publication number
SV1998000003A
SV1998000003A SV1998000003A SV1998000003A SV1998000003A SV 1998000003 A SV1998000003 A SV 1998000003A SV 1998000003 A SV1998000003 A SV 1998000003A SV 1998000003 A SV1998000003 A SV 1998000003A SV 1998000003 A SV1998000003 A SV 1998000003A
Authority
SV
El Salvador
Prior art keywords
separation
isomer
oxima
azabicycle
eters
Prior art date
Application number
SV1998000003A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SV1998000003A publication Critical patent/SV1998000003A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)

Abstract

ES POSIBLE AISLAR EN FORMA LAS OXIMAS AZABICICLO O-SUBSTITUIDAS BIOLOGICAMENTE ACTIVAS QUE POSEEN LA CONFIGURACION Z, SIN NECESIDAD DE EFECTUAR UNA SEPARACION POR CROMATOGRAFICA, Y OBTENER ALTOS RENDIMIENTOS Y PUREZA E/Z MEDIANTE LA UNION DE UN 1-AZABICICLO-3-UNO CON UNA HIDROXILAMINA O-SUBSTITUIDA EN SOLUCION ACUOSA ACIDICA. DEL MISMO MODO, SE PUEDE EFECTUAR LA CONVERSION DE UN ISOMERO CONFIGURADO E A UN ISOMERO Z SIN NECESIDAD DE REALIZAR UNA PURIFICACION O SEPARCION. LA NEUTRALIZACION Y LA SUBSIGUIENTE AISLACION DE LA BASE LIBRE, SEGUIDA POR LA PRECIPITACION DE LA SAL, PERMITE LA SEPARACION DEL ISOMERO Z CON ALTA PUREZA Z/E.
SV1998000003A 1997-01-27 1998-01-14 Proceso para producir eters de oxima (z)-azabiciclo en un unico recipiente SV1998000003A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3597797P 1997-01-27 1997-01-27

Publications (1)

Publication Number Publication Date
SV1998000003A true SV1998000003A (es) 1998-08-13

Family

ID=21885887

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1998000003A SV1998000003A (es) 1997-01-27 1998-01-14 Proceso para producir eters de oxima (z)-azabiciclo en un unico recipiente

Country Status (21)

Country Link
US (1) US6121459A (es)
EP (1) EP1021446A1 (es)
JP (1) JP2001511127A (es)
KR (1) KR20000070464A (es)
AR (1) AR011775A1 (es)
AU (1) AU741566B2 (es)
BR (1) BR9714469A (es)
CA (1) CA2270884A1 (es)
CO (1) CO5011092A1 (es)
GT (1) GT199800019A (es)
HR (1) HRP980040B1 (es)
IL (1) IL129793A (es)
MY (1) MY132840A (es)
NZ (1) NZ335784A (es)
PA (1) PA8445601A1 (es)
PE (1) PE75499A1 (es)
SV (1) SV1998000003A (es)
TW (1) TW533215B (es)
UY (1) UY24857A1 (es)
WO (1) WO1998032758A1 (es)
ZA (1) ZA98618B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5583592B2 (ja) 2007-11-30 2014-09-03 ニューリンク ジェネティクス コーポレイション Ido阻害剤
FR2938534B1 (fr) 2008-11-14 2012-10-26 Sanofi Aventis Procede de preparation de l'hemifumarate d'eplivanserine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158015A (en) * 1978-08-16 1979-06-12 Mobil Oil Corporation Process for the stereoselective synthesis of the E isomer of aryl alkyl oximes
IL97266A0 (en) * 1990-03-06 1992-05-25 Warner Lambert Co Azabicyclo and azacyclo oximes and amines,their preparation and pharmaceutical compositions containing them
US5306718A (en) * 1990-03-06 1994-04-26 Warner-Lambert Company Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment
US5346911A (en) * 1990-03-06 1994-09-13 Warner-Lambert Company Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
AU2782792A (en) * 1991-10-15 1993-05-21 Warner-Lambert Company Azabicyclo oxime and amine cholinergic agents and methods of treatment
DE4203170A1 (de) * 1992-02-05 1993-08-12 Basf Ag Verfahren zur herstellung von e-oximethern von phenylglyoxylsaeureestern
IL107881A0 (en) * 1992-12-05 1994-04-12 Fisons Corp Furanone derivatives and pharmaceutical compositions containing them
US5514812A (en) * 1994-06-10 1996-05-07 Warner-Lambert Company Preparation of stereochemically pure oximes with muscarinic activity

Also Published As

Publication number Publication date
JP2001511127A (ja) 2001-08-07
US6121459A (en) 2000-09-19
AU5806598A (en) 1998-08-18
HRP980040A2 (en) 1998-10-31
MY132840A (en) 2007-10-31
CA2270884A1 (en) 1998-07-30
IL129793A (en) 2003-01-12
NZ335784A (en) 2000-12-22
PA8445601A1 (es) 2000-05-24
CO5011092A1 (es) 2001-02-28
GT199800019A (es) 1999-07-20
TW533215B (en) 2003-05-21
IL129793A0 (en) 2000-02-29
AU741566B2 (en) 2001-12-06
BR9714469A (pt) 2000-05-16
AR011775A1 (es) 2000-09-13
ZA98618B (en) 1998-07-30
WO1998032758A1 (en) 1998-07-30
PE75499A1 (es) 1999-08-20
UY24857A1 (es) 1998-06-25
HRP980040B1 (en) 2002-10-31
KR20000070464A (ko) 2000-11-25
EP1021446A1 (en) 2000-07-26

Similar Documents

Publication Publication Date Title
ES2088425T3 (es) Metodo de produccion de xilitol a partir de mezclas que contienen xilosa.
MX9302432A (es) Mejoras en una membrana de pelicula delgada compuesta en su proceso.
HN1997000110A (es) Derivados del acido arilsulfoonilamino hidroxamico
PT83958B (pt) Processo de preparacao de mono-hidrato do hidrocloreto de n,n-dimetil-1-{1-(4-clorofenil)ciclobutil}-3-metilbutilamina
FI862916A7 (fi) Matalapaineinen elohopeahöyrypurkauslamppu.
MX169089B (es) Metodo para convertir almidon en un producto hidrolizado
IT7904834A0 (it) Procedimento per la desalinizzazione di soluzioni con applicazione della osmosi invertita.
ES2180194T3 (es) Procedimiento para la obtencion de una solucion acuosa de hidroxilamina libre.
ES2098485T3 (es) Complejo que contiene el factor de coagulacion ix.
MX9302279A (es) Metodo para la produccion del factor viii presenteen el plasma, altamente purificado.
AR220434A1 (es) Conjunto para generar ozono,por medio de la aplicacion de tubos generadores
ES2167419T3 (es) Procedimiento de fabricacion de un epoxido.
SV1998000003A (es) Proceso para producir eters de oxima (z)-azabiciclo en un unico recipiente
ES2088877T3 (es) Procedimiento de preparacion del 3-pirrolidinol.
MX9200977A (es) Proceso para producir l-lisina por fermentacion.
ES2183860T3 (es) Procedimiento para producir n-terc butil-2-pirazincarboxamida y n-ter-butil-2-piperazincarboxamida.
ES2090432T3 (es) Preparaciones farmaceuticas con una modificacion cristalina especial del ester isopropil-(2-metoxietilico) del acido 1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-3,5-piridincarboxilico.
KR930016096A (ko) 상처 치유 촉진용 조성물
ES2046437T3 (es) Procedimiento para la separacion de cobre de unas soluciones acuosas de reaccion basica.
ES547371A0 (es) Un procedimiento para eliminar impurezas,que comprenden ami-das,a partir de una solucion que comprende nitrilos y dichasimpurezas
GB932167A (en) Improvements in or relating to low pressure mercury vapour fluorescent electric discharge lamps
IT8723088A0 (it) Dispositivo per la ricerca del capo di filo spezzato su una spola in formazione.
ECSP931002A (es) Medicamentos
TH1384S1 (th) ขวด
RU2000105080A (ru) Препарат для лечения гриппа

Legal Events

Date Code Title Description
FG Grant